RIO DE JANEIRO/BRASILIA (Reuters) - A Brazilian technology institute said on Wednesday it expects to produce a controversial coronavirus Russian vaccine by the second half of 2021, shortly after the state of Parana signed a memorandum of understanding with Moscow.
Russia has touted it as the world's first registered coronavirus vaccine, although experts have also raised safety concerns for going to market while other pharmaceutical companies are still carrying out mass testing.
Already a subscriber? Log in.
Celebrate Merdeka with 50% Off!
T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
